Search Results

Site Search

Mayo Clinic Laboratory and pathology research roundup: April 4 - Insights

This week's Research Roundup features: Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.

Mayo Clinic Laboratory and pathology research roundup: April 18 - Insights

This week's Research Roundup feature: Renal involvement in systemic sclerosis.

Mayo Clinic Laboratory and pathology research roundup: April 25 - Insights

This week's Research Roundup feature: Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.

Mayo Clinic Laboratory and pathology research roundup: May 23 - Insights

This week's research roundup feature: Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.

Mayo Clinic Laboratory and pathology research roundup: March 14 - Insights

This week's Research Roundup features: Novel through-the-scope suture closure of colonic Endoscopic Mucosal resection defects.

Mayo Clinic Laboratory and pathology research roundup: March 28 - Insights

This week's Research Roundup features: Elementary overview of heavy metals.

Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights

This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.

Mayo Clinic Laboratory and pathology research roundup: September 5 - Insights

This week's research roundup feature: 16S rRNA gene PCR/Sequencing of heart valves for diagnosis of infective endocarditis in routine clinical practice.

Mayo Clinic Laboratory and pathology research roundup: June 6 - Insights

This week's research roundup feature: Utilizing mass spectrometry to detect and isotype monoclonal proteins in urine: Comparison to electrophoretic methods.

Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights

This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.